Table 2. Nuclear translocation of p65 in... | American Society of Hematology

Table 2.

Nuclear translocation of p65 in BM cells of MDS patients

Patient no.	BM blasts, %		KA⁺ cells, %			KA^– cells, %
Patient no.	BM blasts, %			Karyotype	p65^Nuc	p65^Cyt	p65^Nuc	p65^Cyt
23	2	47, XY, +8	5	28	< 1	67
26	4	47, XY, +8	6	38	< 1	56
28	7	47, XX, +8	6	23	< 1	71
29	9	47, XY, +8	13	50	< 1	37
30	9	47, XY, +8	14	33	< 1	53
31	15	47, XX, +8	23	47	< 1	30
33	49	47, XX, +8	53	16	< 1	31
50	2	45, XY, –7	2	44	< 1	54
51	3	45, XX, –7	2	49	< 1	49
52	8	45, XY, –7	10	26	< 1	64
54	19	45, XX, –7	22	28	< 1	50
55	48	45, XX, –7	49	10	< 1	41

Patient no.	BM blasts, %		KA⁺ cells, %			KA^– cells, %
Patient no.	BM blasts, %			Karyotype	p65^Nuc	p65^Cyt	p65^Nuc	p65^Cyt
23	2	47, XY, +8	5	28	< 1	67
26	4	47, XY, +8	6	38	< 1	56
28	7	47, XX, +8	6	23	< 1	71
29	9	47, XY, +8	13	50	< 1	37
30	9	47, XY, +8	14	33	< 1	53
31	15	47, XX, +8	23	47	< 1	30
33	49	47, XX, +8	53	16	< 1	31
50	2	45, XY, –7	2	44	< 1	54
51	3	45, XX, –7	2	49	< 1	49
52	8	45, XY, –7	10	26	< 1	64
54	19	45, XX, –7	22	28	< 1	50
55	48	45, XX, –7	49	10	< 1	41

KA indicates karyotype abnormal; Nuc, nuclear; and Cyt, cytosolic.